Contract №13243480 Pharmaceutical products. Winner: Aurobindo Pharma BV

Link to original

To view links to the source need to register

Publication date

18-02-2019

Description

Section I
1. Name and addresses
  Centre hospitalier universitaire de Liège
  Sart Tilman B35
  Liège
  4000
  Belgium
  E-mail: [email protected]
2. Type of the contracting authority:
  Other type: Hôpital universitaire
3. Main activity:
  Health
Section II
1. Scope of the procurement:
  1. Title:
    Conclusion d’un accord-cadre en vue de la fourniture des médicaments anticancéreux utilisés à la pharmacie du CHU de Liège et du CHR de la Citadelle pour une durée de 4 ans
    Reference number: CHULG/18.007
  2. Main CPV code:
    33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000, 33600000
  3. Type of contract:
    Supplies
  4. Short description:
    Le marché a pour objet la conclusion d’un accord-cadre avec 3 fournisseurs par lot (pour autant qu’au moins trois offres sélectionnées et régulières aient été retenues) en vue de la fourniture des médicaments utilisés dans les protocoles de chimiothérapie anticancéreuse à la pharmacie du CHU de Liège et du CHR de la Citadelle tels que repris dans le répertoire commenté des médicaments (CBIP).
    Le cahier des charges peut être obtenu au format .pdf et .doc sur simple demande au service des marchés publics adressée à [email protected] avec la mention: «DDE CSCH — CHULG/18.007».
    En cas d"envoi par mail et en cas de divergence éventuelle entre le modèle .pdf et le modèle.doc, c"est le 1er document (modèle .pdf) qui fait foi.
  5. Information about lots:
    This contract is divided into lots: yes
  6. Total value of the procurement:
    Value excluding VAT: 909 414.49 EUR
2. Description
  1. Title:
    Lot 1: carboplatine (dosage 600 mg/60 ml)
  2. Additional CPV code(s):
    33600000
  3. Place of performance:
    Main site or place of performance:
    Plusieurs lieux.
  4. Description of the procurement:
    Voir II.2.1).
  5. Award criteria:
    Quality criterion - Name: Voir CSCH / Weighting: 0
    Cost criterion - Weighting: 0
  6. Information about options:
    Options: no
  7. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  8. Additional information:
  9. Title:
    Lot 2: cisplatine (dosage 100 mg/100 ml)
  10. Additional CPV code(s):
    33600000
  11. Place of performance:
    Main site or place of performance:
    Plusieurs lieux.
  12. Description of the procurement:
    Voir II.2.1).
  13. Award criteria:
    Quality criterion - Name: Voir CSCH / Weighting: 0
    Cost criterion - Weighting: 0
  14. Information about options:
    Options: no
  15. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  16. Additional information:
  17. Title:
    Lot 3: oxaliplatine (dosage 200 mg/40 ml)
  18. Additional CPV code(s):
    33600000
  19. Place of performance:
    Main site or place of performance:
    Plusieurs lieux.
  20. Description of the procurement:
    Voir II.2.1).
  21. Award criteria:
    Quality criterion - Name: Voir CSCH / Weighting: 0
    Cost criterion - Weighting: 0
  22. Information about options:
    Options: no
  23. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  24. Additional information:
  25. Title:
    Lot 4: bendamustine (dosages 25 et 100 mg)
  26. Additional CPV code(s):
    33600000
  27. Place of performance:
    Main site or place of performance:
    Plusieurs lieux.
  28. Description of the procurement:
    Voir II.2.1).
  29. Award criteria:
    Quality criterion - Name: Voir CSCH / Weighting: 0
    Cost criterion - Weighting: 0
  30. Information about options:
    Options: no
  31. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  32. Additional information:
  33. Title:
    Lot 5: méthotrexate (dosage 5 mg/2 ml)
  34. Additional CPV code(s):
    33600000
  35. Place of performance:
    Main site or place of performance:
    Plusieurs lieux.
  36. Description of the procurement:
    Voir II.2.1).
  37. Award criteria:
    Quality criterion - Name: Voir CSCH / Weighting: 0
    Cost criterion - Weighting: 0
  38. Information about options:
    Options: no
  39. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  40. Additional information:
  41. Title:
    Lot 6: méthotrexate (dosage 500 mg/20 ml)
  42. Additional CPV code(s):
    33600000
  43. Place of performance:
    Main site or place of performance:
    Plusieurs lieux.
  44. Description of the procurement:
    Voir II.2.1).
  45. Award criteria:
    Quality criterion - Name: Voir CSCH / Weighting: 0
    Cost criterion - Weighting: 0
  46. Information about options:
    Options: no
  47. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  48. Additional information:
  49. Title:
    Lot 7: méthotrexate (dosage 1 g /x ml)
  50. Additional CPV code(s):
    33600000
  51. Place of performance:
    Main site or place of performance:
    Centre hospitalier universitaire de Liège, Sart Tilman B35 à 4000 Liège.
  52. Description of the procurement:
    Voir II.2.1).
  53. Award criteria:
    Quality criterion - Name: Voir CSCH / Weighting: 0
    Cost criterion - Weighting: 0
  54. Information about options:
    Options: no
  55. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  56. Additional information:
  57. Title:
    Lot 8: fludarabine (dosage 50 mg/2 ml)
  58. Additional CPV code(s):
    33600000
  59. Place of performance:
    Main site or place of performance:
    Plusieurs lieux.
  60. Description of the procurement:
    Voir II.2.1).
  61. Award criteria:
    Quality criterion - Name: Voir CSCH / Weighting: 0
    Cost criterion - Weighting: 0
  62. Information about options:
    Options: no
  63. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  64. Additional information:
  65. Title:
    Lot 9: cytarabine IT (dosage 100 mg/2 ml)
  66. Additional CPV code(s):
    33600000
  67. Place of performance:
    Main site or place of performance:
    Plusieurs lieux.
  68. Description of the procurement:
    Voir II.2.1).
  69. Award criteria:
    Quality criterion - Name: Voir CSCH / Weighting: 0
    Cost criterion - Weighting: 0
  70. Information about options:
    Options: no
  71. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  72. Additional information:
  73. Title:
    Lot 10: cytarabine (dosage 2 g/20 ml)
  74. Additional CPV code(s):
    33600000
  75. Place of performance:
    Main site or place of performance:
    Plusieurs lieux.
  76. Description of the procurement:
    Voir II.2.1).
  77. Award criteria:
    Quality criterion - Name: Voir CSCH / Weighting: 0
    Cost criterion - Weighting: 0
  78. Information about options:
    Options: no
  79. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  80. Additional information:
  81. Title:
    Lot 11: fluorouracile (dosage 5 g/100 ml)
  82. Additional CPV code(s):
    33600000
  83. Place of performance:
    Main site or place of performance:
    Plusieurs lieux.
  84. Description of the procurement:
    Voir II.2.1).
  85. Award criteria:
    Quality criterion - Name: Voir CSCH / Weighting: 0
    Cost criterion - Weighting: 0
  86. Information about options:
    Options: no
  87. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  88. Additional information:
  89. Title:
    Lot 12: gemcitabine (dosage 2 g/x ml)
  90. Additional CPV code(s):
    33600000
  91. Place of performance:
    Main site or place of performance:
    Plusieurs lieux.
  92. Description of the procurement:
    Voir II.2.1).
  93. Award criteria:
    Quality criterion - Name: Voir CSCH / Weighting: 0
    Cost criterion - Weighting: 0
  94. Information about options:
    Options: no
  95. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  96. Additional information:
  97. Title:
    Lot 13: doxorubicine (dosage 200 mg/100 ml)
  98. Additional CPV code(s):
    33600000
  99. Place of performance:
    Main site or place of performance:
    Plusieurs lieux.
  100. Description of the procurement:
    Voir II.2.1).
  101. Award criteria:
    Quality criterion - Name: Voir CSCH / Weighting: 0
    Cost criterion - Weighting: 0
  102. Information about options:
    Options: no
  103. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  104. Additional information:
  105. Title:
    Lot 14: épirubicine (dosage 200 mg/100 ml)
  106. Additional CPV code(s):
    33600000
  107. Place of performance:
    Main site or place of performance:
    Plusieurs lieux.
  108. Description of the procurement:
    Voir II.2.1).
  109. Award criteria:
    Quality criterion - Name: Voir CSCH / Weighting: 0
    Cost criterion - Weighting: 0
  110. Information about options:
    Options: no
  111. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  112. Additional information:
  113. Title:
    Lot 15: idarubicine (dosage 10 mg/10 ml)
  114. Additional CPV code(s):
    33600000
  115. Place of performance:
    Main site or place of performance:
    Plusieurs lieux.
  116. Description of the procurement:
    Voir II.2.1).
  117. Award criteria:
    Quality criterion - Name: Voir CSCH / Weighting: 0
    Cost criterion - Weighting: 0
  118. Information about options:
    Options: no
  119. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  120. Additional information:
  121. Title:
    Lot 16: mitoxantrone (dosage 20 mg/10 ml)
  122. Additional CPV code(s):
    33600000
  123. Place of performance:
    Main site or place of performance:
    Plusieurs lieux.
  124. Description of the procurement:
    Voir II.2.1).
  125. Award criteria:
    Quality criterion - Name: Voir CSCH / Weighting: 0
    Cost criterion - Weighting: 0
  126. Information about options:
    Options: no
  127. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  128. Additional information:
  129. Title:
    Lot 17: irinotecan (dosage 500 mg/25 ml)
  130. Additional CPV code(s):
    33600000
  131. Place of performance:
    Main site or place of performance:
    Plusieurs lieux.
  132. Description of the procurement:
    Voir II.2.1).
  133. Award criteria:
    Quality criterion - Name: Voir CSCH / Weighting: 0
    Cost criterion - Weighting: 0
  134. Information about options:
    Options: no
  135. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  136. Additional information:
  137. Title:
    Lot 18: étoposide (dosage 500 mg/25 ml)
  138. Additional CPV code(s):
    33600000
  139. Place of performance:
    Main site or place of performance:
    Plusieurs lieux.
  140. Description of the procurement:
    Voir II.2.1).
  141. Award criteria:
    Quality criterion - Name: Voir CSCH / Weighting: 0
    Cost criterion - Weighting: 0
  142. Information about options:
    Options: no
  143. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  144. Additional information:
  145. Title:
    Lot 19: vinorelbine (dosage 50 mg/5 ml)
  146. Additional CPV code(s):
    33600000
  147. Place of performance:
    Main site or place of performance:
    Plusieurs lieux.
  148. Description of the procurement:
    Voir II.2.1).
  149. Award criteria:
    Quality criterion - Name: Voir CSCH / Weighting: 0
    Cost criterion - Weighting: 0
  150. Information about options:
    Options: no
  151. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  152. Additional information:
  153. Title:
    Lot 20: docétaxel (dosage 160 mg/8 ml)
  154. Additional CPV code(s):
    33600000
  155. Place of performance:
    Main site or place of performance:
    Plusieurs lieux.
  156. Description of the procurement:
    Voir II.2.1).
  157. Award criteria:
    Quality criterion - Name: Voir CSCH / Weighting: 0
    Cost criterion - Weighting: 0
  158. Information about options:
    Options: no
  159. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  160. Additional information:
  161. Title:
    Lot 21: paclitaxel (dosage 600 mg/100 ml)
  162. Additional CPV code(s):
    33600000
  163. Place of performance:
    Main site or place of performance:
    Plusieurs lieux.
  164. Description of the procurement:
    Voir II.2.1).
  165. Award criteria:
    Quality criterion - Name: Voir CSCH / Weighting: 0
    Cost criterion - Weighting: 0
  166. Information about options:
    Options: no
  167. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  168. Additional information:
  169. Title:
    Lot 22: témozolomide (dosages 5, 20, 100, 250 mg)
  170. Additional CPV code(s):
    33600000
  171. Place of performance:
    Main site or place of performance:
    Plusieurs lieux.
  172. Description of the procurement:
    Voir II.2.1).
  173. Award criteria:
    Quality criterion - Name: Voir CSCH / Weighting: 0
    Cost criterion - Weighting: 0
  174. Information about options:
    Options: no
  175. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  176. Additional information:
  177. Title:
    Lot 23: capécitabine (dosage 150 mg)
  178. Additional CPV code(s):
    33600000
  179. Place of performance:
    Main site or place of performance:
    Plusieurs lieux.
  180. Description of the procurement:
    Voir II.2.1).
  181. Award criteria:
    Quality criterion - Name: Voir CSCH / Weighting: 0
    Cost criterion - Weighting: 0
  182. Information about options:
    Options: no
  183. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  184. Additional information:
  185. Title:
    Lot 24: imatinib (dosages 100 et 400 mg)
  186. Additional CPV code(s):
    33600000
  187. Place of performance:
    Main site or place of performance:
    Plusieurs lieux.
  188. Description of the procurement:
    Voir II.2.1).
  189. Award criteria:
    Quality criterion - Name: Voir CSCH / Weighting: 0
    Cost criterion - Weighting: 0
  190. Information about options:
    Options: no
  191. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  192. Additional information:
  193. Title:
    Lot 25: létrozole (dosage 2,5 mg en boîtes de 30 CP)
  194. Additional CPV code(s):
    33600000
  195. Place of performance:
    Main site or place of performance:
    Plusieurs lieux.
  196. Description of the procurement:
    Voir II.2.1).
  197. Award criteria:
    Quality criterion - Name: Voir CSCH / Weighting: 0
    Cost criterion - Weighting: 0
  198. Information about options:
    Options: no
  199. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  200. Additional information:
  201. Title:
    Lot 26: méthotrexate (dosages 1 g /x ml et 5 g /50 ml)
  202. Additional CPV code(s):
    33600000
  203. Place of performance:
    Main site or place of performance:
    Centre hospitalier régional de la Citadelle, bd du 12e de Ligne à 4000 Liège.
  204. Description of the procurement:
    Voir II.2.1).
  205. Award criteria:
    Quality criterion - Name: Voir CSCH / Weighting: 0
    Cost criterion - Weighting: 0
  206. Information about options:
    Options: no
  207. Information about European Union funds:
    The procurement is related to a project and/or programme financed by European Union funds: no
  208. Additional information:
Section IV
1. Description:
  1. Type of procedure:
    Open procedure
  2. Information about a framework agreement or a dynamic purchasing system:
    The procurement involves the establishment of a framework agreement
  3. Information about electronic auction:
  4. Information about the Government Procurement Agreement (GPA):
    The procurement is covered by the Government Procurement Agreement: yes
2. Administrative information:
  1. Previous publication concerning this procedure:
    Notice number in the OJ S: 2018/S 131-298411
  2. Information about termination of dynamic purchasing system:
  3. Information about termination of call for competition in the form of a prior information notice:
Section V
1. Contract No: CHULG/18.007
  Lot No: 1
  Title:
  Lot 1: carboplatine (dosage 600 mg/60 ml)
2. Award of contract
  1. Date of conclusion of the contract: 2019-01-31
  2. Information about tenders:
    Number of tenders received: 3
    Number of tenders received from tenderers from other EU Member States: 0
    Number of tenders received from tenderers from non-EU Member States: 0
    The contract has been awarded to a group of economic operators: no
  3. Name and address of the contractor:
    Accord Healthcare
    Groeneweg 17
    Aalst
    9320
    Belgium
    The contractor is an SME: no
  4. Information on value of the contract/lot (excluding VAT):
    
    Total value of the contract/lot: 101 160.00 EUR
  5. Information about subcontracting:
    
    Contract No: CHULG/18.007
    Lot No: 2
    Title:
    Lot 2: cisplatine (dosage 100 mg/100 ml)
  6. Award of contract
    1. Date of conclusion of the contract: 2019-01-31
    2. Information about tenders:
      Number of tenders received: 2
      Number of tenders received from tenderers from other EU Member States: 0
      Number of tenders received from tenderers from non-EU Member States: 0
      The contract has been awarded to a group of economic operators: no
    3. Name and address of the contractor:
      Accord Healthcare
      Groeneweg 17
      Aalst
      9320
      Belgium
      The contractor is an SME: no
    4. Information on value of the contract/lot (excluding VAT):
      
      Total value of the contract/lot: 48 391.20 EUR
    5. Information about subcontracting:
      
      Contract No: CHULG/18.007
      Lot No: 3
      Title:
      Lot 3: oxaliplatine (dosage 200 mg/40 ml)
    6. Award of contract
      1. Date of conclusion of the contract: 2019-01-31
      2. Information about tenders:
        Number of tenders received: 3
        Number of tenders received from tenderers from other EU Member States: 0
        Number of tenders received from tenderers from non-EU Member States: 0
        The contract has been awarded to a group of economic operators: no
      3. Name and address of the contractor:
        Accord Healthcare
        Groeneweg 17
        Aalst
        9320
        Belgium
        The contractor is an SME: no
      4. Information on value of the contract/lot (excluding VAT):
        
        Total value of the contract/lot: 46 508.00 EUR
      5. Information about subcontracting:
        
        Contract No: CHULG/18.007
        Lot No: 4
        Title:
        Lot 4: bendamustine (dosages 25 et 100 mg)
      6. Award of contract
        Date of conclusion of the contract: 2019-01-31
        Information about tenders:
        Number of tenders received: 2
        Number of tenders received from tenderers from other EU Member States: 0
        Number of tenders received from tenderers from non-EU Member States: 0
        The contract has been awarded to a group of economic operators: no
        Name and address of the contractor:
        Accord Healthcare
        Groeneweg 17
        Aalst
        9320
        Belgium
        The contractor is an SME: no
        Information on value of the contract/lot (excluding VAT):
        
        Total value of the contract/lot: 50 513.32 EUR
        Information about subcontracting:
        
        Contract No: CHULG/18.007
        Lot No: 5
        Title:
        Lot 5: méthotrexate (dosage 5 mg/2 ml)
        Award of contract
        Date of conclusion of the contract: 2019-01-31
        Information about tenders:
        Number of tenders received: 1
        Number of tenders received from SMEs: 0
        Number of tenders received from tenderers from other EU Member States: 0
        Number of tenders received from tenderers from non-EU Member States: 0
        The contract has been awarded to a group of economic operators: no
        Name and address of the contractor:
        Teva Pharma Belgium
        Laarstraat 16
        Wilrijk
        2610
        Belgium
        The contractor is an SME: no
        Information on value of the contract/lot (excluding VAT):
        
        Total value of the contract/lot: 1 763.20 EUR
        Information about subcontracting:
        
        Contract No: CHULG/18.007
        Lot No: 6
        Title:
        Lot 6: méthotrexate (dosage 500 mg/20 ml)
        Award of contract
        Date of conclusion of the contract: 2019-01-31
        Information about tenders:
        Number of tenders received: 1
        Number of tenders received from SMEs: 0
        Number of tenders received from tenderers from other EU Member States: 0
        Number of tenders received from tenderers from non-EU Member States: 0
        The contract has been awarded to a group of economic operators: no
        Name and address of the contractor:
        Teva Pharma Belgium
        Laarstraat 16
        Wilrijk
        2610
        Belgium
        The contractor is an SME: no
        Information on value of the contract/lot (excluding VAT):
        
        Total value of the contract/lot: 5 934.60 EUR
        Information about subcontracting:
        
        Contract No: CHULG/18.007
        Lot No: 7
        Title:
        Lot 7: méthotrexate (dosage 1 g /x ml)
        Award of contract
        Date of conclusion of the contract: 2019-01-31
        Information about tenders:
        Number of tenders received: 1
        Number of tenders received from SMEs: 0
        Number of tenders received from tenderers from other EU Member States: 0
        Number of tenders received from tenderers from non-EU Member States: 0
        The contract has been awarded to a group of economic operators: no
        Name and address of the contractor:
        Teva Pharma Belgium
        Laarstraat 16
        Wilrijk
        2610
        Belgium
        The contractor is an SME: no
        Information on value of the contract/lot (excluding VAT):
        
        Total value of the contract/lot: 18 796.72 EUR
        Information about subcontracting:
        
        Contract No: CHULG/18.007
        Lot No: 8
        Title:
        Lot 8: fludarabine (dosage 50 mg/2 ml)
        Award of contract
        Date of conclusion of the contract: 2019-01-31
        Information about tenders:
        Number of tenders received: 1
        Number of tenders received from SMEs: 0
        Number of tenders received from tenderers from other EU Member States: 0
        Number of tenders received from tenderers from non-EU Member States: 0
        The contract has been awarded to a group of economic operators: no
        Name and address of the contractor:
        Teva Pharma Belgium
        Laarstraat 16
        Wilrijk
        2610
        Belgium
        The contractor is an SME: no
        Information on value of the contract/lot (excluding VAT):
        
        Total value of the contract/lot: 5 217.92 EUR
        Information about subcontracting:
        
        Contract No: CHULG/18.007
        Lot No: 9
        Title:
        Lot 9: cytarabine IT (dosage 100 mg/2 ml)
        Award of contract
        Date of conclusion of the contract: 2019-01-31
        Information about tenders:
        Number of tenders received: 1
        Number of tenders received from SMEs: 0
        Number of tenders received from tenderers from other EU Member States: 0
        Number of tenders received from tenderers from non-EU Member States: 0
        The contract has been awarded to a group of economic operators: no
        Name and address of the contractor:
        Pfizer
        Boulevard de la Plaine 17
        Bruxelles
        1050
        Belgium
        The contractor is an SME: no
        Information on value of the contract/lot (excluding VAT):
        
        Total value of the contract/lot: 2 104.20 EUR
        Information about subcontracting:
        
        Contract No: CHULG/18.007
        Lot No: 10
        Title:
        Lot 10: cytarabine (dosage 2 g/20 ml)
        Award of contract
        Date of conclusion of the contract: 2019-01-31
        Information about tenders:
        Number of tenders received: 2
        Number of tenders received from tenderers from other EU Member States: 0
        Number of tenders received from tenderers from non-EU Member States: 0
        The contract has been awarded to a group of economic operators: no
        Name and address of the contractor:
        Accord Healthcare
        Groeneweg 17
        Aalst
        9320
        Belgium
        The contractor is an SME: no
        Information on value of the contract/lot (excluding VAT):
        
        Total value of the contract/lot: 21 141.67 EUR
        Information about subcontracting:
        
        Contract No: CHULG/18.007
        Lot No: 11
        Title:
        Lot 11: fluorouracile (dosage 5 g/100 ml)
        Award of contract
        Date of conclusion of the contract: 2019-01-31
        Information about tenders:
        Number of tenders received: 2
        Number of tenders received from tenderers from other EU Member States: 0
        Number of tenders received from tenderers from non-EU Member States: 0
        The contract has been awarded to a group of economic operators: no
        Name and address of the contractor:
        Accord Healthcare
        Groeneweg 17
        Aalst
        9320
        Belgium
        The contractor is an SME: no
        Information on value of the contract/lot (excluding VAT):
        
        Total value of the contract/lot: 69 880.00 EUR
        Information about subcontracting:
        
        Contract No: CHULG/18.007
        Lot No: 12
        Title:
        Lot 12: gemcitabine (dosage 2 g/x ml)
        Award of contract
        Date of conclusion of the contract: 2019-01-31
        Information about tenders:
        Number of tenders received: 6
        Number of tenders received from tenderers from other EU Member States: 1
        Number of tenders received from tenderers from non-EU Member States: 0
        The contract has been awarded to a group of economic operators: no
        Name and address of the contractor:
        Accord Healthcare
        Groeneweg 17
        Aalst
        9320
        Belgium
        The contractor is an SME: no
        Information on value of the contract/lot (excluding VAT):
        
        Total value of the contract/lot: 73 780.00 EUR
        Information about subcontracting:
        
        Contract No: CHULG/18.007
        Lot No: 13
        Title:
        Lot 13: doxorubicine (dosage 200 mg/100 ml)
        Award of contract
        Date of conclusion of the contract: 2019-01-31
        Information about tenders:
        Number of tenders received: 3
        Number of tenders received from tenderers from other EU Member States: 0
        Number of tenders received from tenderers from non-EU Member States: 0
        The contract has been awarded to a group of economic operators: no
        Name and address of the contractor:
        Teva Pharma Belgium
        Laarstraat 16
        Wilrijk
        2610
        Belgium
        The contractor is an SME: no
        Information on value of the contract/lot (excluding VAT):
        
        Total value of the contract/lot: 18 741.48 EUR
        Information about subcontracting:
        
        Contract No: CHULG/18.007
        Lot No: 14
        Title:
        Lot 14: épirubicine (dosage 200 mg/100 ml)
        Award of contract
        Date of conclusion of the contract: 2019-01-31
        Information about tenders:
        Number of tenders received: 4
        Number of tenders received from tenderers from other EU Member States: 1
        Number of tenders received from tenderers from non-EU Member States: 0
        The contract has been awarded to a group of economic operators: no
        Name and address of the contractor:
        Teva Pharma Belgium
        Laarstraat 16
        Wilrijk
        2610
        Belgium
        The contractor is an SME: no
        Information on value of the contract/lot (excluding VAT):
        
        Total value of the contract/lot: 70 918.52 EUR
        Information about subcontracting:
        
        Contract No: CHULG/18.007
        Lot No: 15
        Title:
        Lot 15: idarubicine (dosage 10 mg/10 ml)
        Contract No: CHULG/18.007
        Lot No: 16
        Title:
        Lot 16: mitoxantrone (dosage 20 mg/10 ml)
        Contract No: CHULG/18.007
        Lot No: 17
        Title:
        Lot 17: irinotecan (dosage 500 mg/25 ml)
        Award of contract
        Date of conclusion of the contract: 2019-01-31
        Information about tenders:
        Number of tenders received: 3
        Number of tenders received from tenderers from other EU Member States: 1
        Number of tenders received from tenderers from non-EU Member States: 0
        The contract has been awarded to a group of economic operators: no
        Name and address of the contractor:
        Accord Healthcare
        Groeneweg 17
        Aalst
        9320
        Belgium
        The contractor is an SME: no
        Information on value of the contract/lot (excluding VAT):
        
        Total value of the contract/lot: 43 677.32 EUR
        Information about subcontracting:
        
        Contract No: CHULG/18.007
        Lot No: 18
        Title:
        Lot 18: étoposide (dosage 500 mg/25 ml)
        Award of contract
        Date of conclusion of the contract: 2019-01-31
        Information about tenders:
        Number of tenders received: 1
        Number of tenders received from SMEs: 0
        Number of tenders received from tenderers from other EU Member States: 0
        Number of tenders received from tenderers from non-EU Member States: 0
        The contract has been awarded to a group of economic operators: no
        Name and address of the contractor:
        Teva Pharma Belgium
        Laarstraat 16
        Wilrijk
        2610
        Belgium
        The contractor is an SME: no
        Information on value of the contract/lot (excluding VAT):
        
        Total value of the contract/lot: 21 934.64 EUR
        Information about subcontracting:
        
        Contract No: CHULG/18.007
        Lot No: 19
        Title:
        Lot 19: vinorelbine (dosage 50 mg/5 ml)
        Award of contract
        Date of conclusion of the contract: 2019-01-31
        Information about tenders:
        Number of tenders received: 1
        Number of tenders received from SMEs: 0
        Number of tenders received from tenderers from other EU Member States: 1
        Number of tenders received from tenderers from non-EU Member States: 0
        The contract has been awarded to a group of economic operators: no
        Name and address of the contractor:
        Aurobindo Pharma BV
        Baarnsche Dijk 1
        LN Baarn
        3741
        Netherlands
        Telephone: +31 355429933
        E-mail: [email protected]
        The contractor is an SME: no
        Information on value of the contract/lot (excluding VAT):
        
        Total value of the contract/lot: 64 878.64 EUR
        Information about subcontracting:
        
        Contract No: CHULG/18.007
        Lot No: 20
        Title:
        Lot 20: docétaxel (dosage 160 mg/8 ml)
        Award of contract
        Date of conclusion of the contract: 2019-01-31
        Information about tenders:
        Number of tenders received: 2
        Number of tenders received from tenderers from other EU Member States: 1
        Number of tenders received from tenderers from non-EU Member States: 0
        The contract has been awarded to a group of economic operators: no
        Name and address of the contractor:
        Accord Healthcare
        Groeneweg 17
        Aalst
        9320
        Belgium
        The contractor is an SME: no
        Information on value of the contract/lot (excluding VAT):
        
        Total value of the contract/lot: 27 245.32 EUR
        Information about subcontracting:
        
        Contract No: CHULG/18.007
        Lot No: 21
        Title:
        Lot 21: paclitaxel (dosage 600 mg/100 ml)
        Award of contract
        Date of conclusion of the contract: 2018-12-19
        Information about tenders:
        Number of tenders received: 2
        Number of tenders received from tenderers from other EU Member States: 0
        Number of tenders received from tenderers from non-EU Member States: 0
        The contract has been awarded to a group of economic operators: no
        Name and address of the contractor:
        Fresenius Kabi
        Brandekensweg 9
        Schelle
        2627
        Belgium
        The contractor is an SME: no
        Information on value of the contract/lot (excluding VAT):
        
        Total value of the contract/lot: 119 970.28 EUR
        Information about subcontracting:
        
        Contract No: CHULG/18.007
        Lot No: 22
        Title:
        Lot 22: témozolomide (dosages 5, 20, 100, 250 mg)
        Award of contract
        Date of conclusion of the contract: 2019-01-31
        Information about tenders:
        Number of tenders received: 2
        Number of tenders received from tenderers from other EU Member States: 0
        Number of tenders received from tenderers from non-EU Member States: 0
        The contract has been awarded to a group of economic operators: no
        Name and address of the contractor:
        Accord Healthcare
        Groeneweg 17
        Aalst
        9320
        Belgium
        The contractor is an SME: no
        Information on value of the contract/lot (excluding VAT):
        
        Total value of the contract/lot: 44 102.68 EUR
        Information about subcontracting:
        
        Contract No: CHULG/18.007
        Lot No: 23
        Title:
        Lot 23: capécitabine (dosage 150 mg)
        Award of contract
        Date of conclusion of the contract: 2019-01-31
        Information about tenders:
        Number of tenders received: 1
        Number of tenders received from tenderers from other EU Member States: 0
        Number of tenders received from tenderers from non-EU Member States: 0
        The contract has been awarded to a group of economic operators: no
        Name and address of the contractor:
        Accord Healthcare
        Groeneweg 17
        Aalst
        9320
        Belgium
        The contractor is an SME: no
        Information on value of the contract/lot (excluding VAT):
        
        Total value of the contract/lot: 3 784.00 EUR
        Information about subcontracting:
        
        Contract No: CHULG/18.007
        Lot No: 24
        Title:
        Lot 24: imatinib (dosages 100 et 400 mg)
        Contract No: CHULG/18.007
        Lot No: 25
        Title:
        Lot 25: létrozole (dosage 2,5 mg en boîtes de 30 CP)
        Award of contract
        Date of conclusion of the contract: 2019-01-31
        Information about tenders:
        Number of tenders received: 4
        Number of tenders received from SMEs: 0
        Number of tenders received from tenderers from other EU Member States: 1
        Number of tenders received from tenderers from non-EU Member States: 0
        The contract has been awarded to a group of economic operators: no
        Name and address of the contractor:
        Teva Pharma Belgium
        Laarstraat 16
        Wilrijk
        2610
        Belgium
        The contractor is an SME: no
        Information on value of the contract/lot (excluding VAT):
        
        Total value of the contract/lot: 2 947.58 EUR
        Information about subcontracting:
        
        Contract No: CHULG/18.007
        Lot No: 26
        Title:
        Lot 26: méthotrexate (dosages 1 g /x ml et 5 g /50 ml)
        Award of contract
        Date of conclusion of the contract: 2019-01-31
        Information about tenders:
        Number of tenders received: 1
        Number of tenders received from SMEs: 0
        Number of tenders received from tenderers from other EU Member States: 0
        Number of tenders received from tenderers from non-EU Member States: 0
        The contract has been awarded to a group of economic operators: no
        Name and address of the contractor:
        Teva Pharma Belgium
        Laarstraat 16
        Wilrijk
        2610
        Belgium
        The contractor is an SME: no
        Information on value of the contract/lot (excluding VAT):
        
        Total value of the contract/lot: 46 023.20 EUR
        Information about subcontracting:
        
        Section VI
        Additional information
        Procedures for review
        Review body
        Conseil d"État
        Rue de la Science 37
        Bruxelles
        1040
        Belgium
        Telephone: +32 22439611
        Body responsible for mediation procedures
        
        Service from which information about the review procedure may be obtained
        
        Date of dispatch of this notice
        2019-02-13

Pharmaceutical products (№13243480)

Link to original

Publication date

Description